A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: round (299), curved (13), smoothed (54)

Vinorelbine (oral day 1 and 8)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Oral) (Day 1 and 8) This protocol may require funding Regim
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineoralday1and8ver11.pdf

Vinflunine

Description
Chemotherapy Protocol BLADDER Regimen VINFLUNINE • Bladder – Vinflunine Indication • Bladder cancer that has failed to respond or progressed with in twelve months
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Vinflunine.pdf

Temsirolimus v1.1

Description
Chemotherapy Protocol RENAL CELL TEMSIROLIMUS This protocol may require funding Regimen Renal Cell - Temsirolimus Indi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Temsirolimus-v1.1.pdf

Rituximab (8 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma as fir
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

Rituximab (12 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (12 weekly) Regimen Lymphoma – Rituximab (12 Weekly) Indication Non- Hodgkin’s Lymphoma as
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-12-weekly.pdf

Ibrutinib (MCL) (560mg)

Description
Chemotherapy Protocol Mantle Cell Lymphoma Regimen Ibrutinib • MCL – Ibrutinib (560mg) Indication • Mantle Cell Lymphoma with cyclin D1 overexpr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-MCL-560mg.pdf

Cyclophosphamide-Dactinomycin-Vincristine (VAC) v1

Description
Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-DACTINOMYCIN-VINCRISTINE (VAC) Regimen Sarcoma-Cyclophosphamide-Dactin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Dactinomycin-Vincristine-VAC-v1.pdf

Paediatric high dependency unit (PHDU) - patient information

Description
This factsheet gives information about the paediatric high dependency unit (PHDU).
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Paediatric-high-dependency-unit-PHDU-2536-PIL.pdf

CH003 regimen validation checklist ver2.0x

Description
Central South Coast Cancer Network Strength through Partnership Checklist for Verification of Treatment Regimens in ARIA Version 10 Regimen’s Name
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003regimenvalidationchecklistver20x.pdf

SHC_application_2021_final2

Description
Southampton Hospitals Charity Research Funding Award 2022 Southampton Hospitals Charity (SHC) has actively engaged in raising funds for research projects ove
Url
/Media/Southampton-Clinical-Research/Grants/Download/SHC-application-2021-final2.docx
211 to 220 of 299
Previous … 20 21 22 23 24 … Next